Fanny Lemarié | Medicine | Best Researcher Award

Best Researcher Award

Fanny Lemarié
Service d’Hématologie et d’Hémostase clinique, Institut de Cancéro-Hématologie, CHU de Brest, Brest, France

Fanny Lemarié
Affiliation Service d’Hématologie et d’Hémostase clinique, Institut de Cancéro-Hématologie, CHU de Brest
Country France
Documents 2
Subject Area Medicine
Event International Popular Scientist Awards
ORCID 0009-0007-5938-7122

Fanny Lemarié is a medical researcher affiliated with the Service d’Hématologie et d’Hémostase clinique, Institut de Cancéro-Hématologie, CHU de Brest, in Brest, France. Her documented research output includes two indexed documents in the field of Medicine. This academic profile presents her research background, scholarly contributions, publication record, potential research impact, and suitability for consideration for the Best Researcher Award within the International Popular Scientist Awards.

Abstract

This academic recognition profile presents Fanny Lemarié, a medical researcher based at the Service d’Hématologie et d’Hémostase clinique, Institut de Cancéro-Hématologie, CHU de Brest, France. The available profile records two research documents and identifies Medicine as the principal subject area. Her institutional setting places her scholarly activities within a specialized clinical environment concerned with hematology, hemostasis, and cancer-related medical research. The profile is intended to provide a structured scholarly overview rather than an independent assessment of research quality. Bibliographic information should be interpreted alongside authoritative researcher and publication databases. [1]

Keywords

Fanny Lemarié; Medicine; Hematology; Hemostasis; Cancer Research; Clinical Research; CHU de Brest; Brest; France; Medical Research.

Introduction

Clinical hematology and hemostasis are multidisciplinary areas of medicine that integrate laboratory investigation, diagnosis, patient management, and translational research. Research conducted in these settings can contribute to improved understanding of hematological disorders, coagulation processes, malignancies, treatment response, and patient-centered clinical care.[1]

Research Profile

The research profile of Fanny Lemarié is situated within Medicine and is institutionally connected to a specialized hematology and hemostasis service. The affiliation with the Institut de Cancéro-Hématologie further indicates a professional environment encompassing cancer-related hematological care and research. Such clinical research environments commonly involve interactions between laboratory medicine, hematology, oncology, diagnostic science, and therapeutic practice.

Research Contributions

The available information establishes a scholarly profile in Medicine with a focus connected to clinical hematology and hemostasis. Research conducted in this domain may support the characterization of hematological conditions, investigation of coagulation and bleeding disorders, evaluation of diagnostic approaches, and development or assessment of clinical strategies in hematology and oncology.[1]

Publications

The supplied academic profile records 2 documents for Fanny Lemarié. Complete publication titles, journal information, publication dates, author lists, citation counts, and DOI identifiers were not included in the source data provided for this article. Accordingly, individual publications are not listed here to avoid attributing bibliographic details without verification.[1]

Research Impact

Research impact in clinical medicine may be assessed through several complementary dimensions, including peer-reviewed publications, citations, methodological contributions, clinical translation, collaboration, educational activity, and contribution to evidence-based healthcare. For Fanny Lemarié, the available record confirms two research documents but does not provide verified citation or h-index values. Therefore, quantitative impact beyond the documented publication count cannot be responsibly stated from the supplied information.

Award Suitability

The Best Researcher Award is intended to recognize researchers whose scholarly activity demonstrates meaningful contributions to their respective fields. Based on the information supplied for this profile, Fanny Lemarié has a documented research presence in Medicine and is affiliated with a specialized clinical hematology and hemostasis service at CHU de Brest. These characteristics provide relevant professional context for consideration within a medical research award program.

Conclusion

Fanny Lemarié is a medical researcher affiliated with the Service d’Hématologie et d’Hémostase clinique, Institut de Cancéro-Hématologie, CHU de Brest, France. The supplied profile records two research documents and identifies Medicine as the relevant subject area. Her affiliation places her within a specialized clinical research setting focused on hematology, hemostasis, and cancer-related medicine. The available information supports consideration of her profile for academic recognition, while a comprehensive assessment should incorporate verified publication-level and bibliometric evidence.

References

  1. Elsevier. (n.d.). Scopus author details: Fanny Lemarié. Scopus. Bibliographic and author-profile information supplied for the academic recognition profile.
  2. ORCID. (n.d.). ORCID record for Fanny Lemarié. ORCID.
    https://orcid.org/0009-0007-5938-7122
  3. International Popular Scientist Awards. (n.d.). International Popular Scientist Awards.
    https://popularscientist.com/
  4. Lemarié, F., Picard, J., Galinat, H., Jaouen, S., Pan-Petesch, B., Nicol, C., Herbreteau, L., Civi, L., Rio, L., Lambert, W.-C., et al. (2026). Philadelphia-negative myeloproliferative neoplasms and acquired von Willebrand syndrome.

Yamini Krishna | Medicine | Research Excellence Award

Dr. Yamini Krishna | Medicine | Research Excellence Award

Royal Liverpool University Hospital | United Kingdom

Dr. Yamini Krishna is a clinician-scientist specializing in ophthalmic pathology, integrating diagnostic expertise with translational research in ocular oncology. Her work focuses on tumour pathology, immune microenvironment profiling, and biomarker discovery using advanced techniques such as transcriptomics and digital pathology. She has contributed significantly to scientific literature with 33 publications, achieving 592 citations and an h-index of 13, reflecting strong research impact. Her contributions have advanced diagnostic standards, including cancer reporting datasets. She is actively involved in international collaborations, scientific dissemination, editorial responsibilities, and the mentorship of trainees, supporting academic development and innovation in pathology and vision science.

Citation Metrics (Scopus)

1000

600

450

300

150

0

Citations
592

Documents
33

h-index
13

🟦 Citations    🟥 Documents    🟩 h-index


View Scopus Profile
    View Orcid Profile    View Google Scholar Profile

Featured Publications

Shubana Hayat | Medicine | Research Excellence Award

Ms. Shubana Hayat | Medicine | Research Excellence Award

University of Campania | Italy

Ms. Shubana Hayat is a microbiology researcher with expertise in microbial isolation, characterization, and antimicrobial analysis, focusing on environmental and public health microbiology. Her research explores antimicrobial activities of medicinal plants, microbial contamination in water sources, and bacterial resistance patterns, contributing to sustainable health and sanitation solutions. She has experience in academic teaching, laboratory research assistance, and clinical microbiology practices. Her technical proficiency includes molecular techniques, microbiological assays, and bio-burden analysis. With 24 citations across 7 documents, and an h-index of 2, her work supports advancements in microbiological research, food safety, and environmental sustainability.

Citation Metrics (Scopus)

24

18

12

6

0

Citations
24

Documents
7

h-index
2

🟦 Citations    🟥 Documents    🟩 h-index


View Scopus Profile

Featured Publications

Federica Tonon | Medicine | Research Excellence Distinction Award

Dr. Federica Tonon | Medicine | Research Excellence Distinction Award

Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) | Italy 

Dr. Federica Tonon is a biomedical researcher specializing in molecular biology, translational medicine, and clinical data science, with research focusing on cancer biology, hepatocellular carcinoma, endocrine pathways, and the renin–angiotensin system. Her work integrates advanced experimental models including zebrafish, murine systems, and stem cell technologies to investigate disease mechanisms, biomarkers, and therapeutic strategies. She has contributed to interdisciplinary projects combining laboratory research and clinical data management, supporting precision medicine approaches. Her scholarly impact includes 845 citations across 748 documents, with 38 Document and an h-index of 17, reflecting sustained contributions to biomedical research, innovation, and scientific advancement.

Citation Metrics (Scopus)

900

700

500

300

100

0

Citations
845

Documents
38

h-index
17

🟦 Citations 🟥 Documents 🟩 h-index


View Scopus Profile
   View Orcid Profile

Featured Publications

Lila Wayman | Medical Sciences | Best Researcher Award

Ms. Lila Wayman | Medical Sciences | Best Researcher Award

The University of Arizona, United States

Lila Ty Wayman is an undergraduate researcher at the University of Arizona, pursuing a Bachelor of Science in Physiology and Medical Sciences. With a strong interdisciplinary background in healthcare, biomechanics, and public safety, she has contributed to impactful research on fall risk, slip resistance, and infant injury biomechanics. She currently serves as a Research Associate Intern at Verum Biomechanics LLC, supporting forensic analysis and expert testimony preparation.

Profile:

📊 Research Experience:

  • Research Associate Intern at Verum Biomechanics LLC

  • Undergraduate Research Assistant at SensorLab, University of Arizona

  • Contributor to studies on slip resistance, infant handling forces, and forensic injury analysis

  • Poster presenter & session judge at key academic forums (MEZCOPH, Physiology Poster Session)

📝 Publications (Selected):

  1. High G-Forces in Improper Infant Handling – Forensic Sci (2025)

  2. Dry Particle Thickness & Slip Resistance – J Forensic Sci (2025)

  3. Sand Additives Impact on Floor Safety – EngRxiv (2025)
    [All publications available via DOI links]

🏆 Honors & Leadership:

  • 🥇 President’s Honor List – Glendale Community College

  • 🏅 Blue Chip Leadership Award – University of Arizona

  • 🎓 Member, Phi Theta Kappa Honor Society

  • 📚 Preceptorships in Biology and Physiology

🌍 Impact Focus:

Lila’s applied research contributes to public health, legal safety standards, and forensic science, aiming to prevent accidents and promote evidence-based injury assessment in courts and communities.

Publication Top Notes:

  1. High G-Forces in Unintentionally Improper Infant Handling: Implications for Shaken Baby Syndrome Diagnosis
    📅 Published: June 2025
    🧪 Journal: Forensic Sciences
    🔗 DOI: 10.3390/forensicsci5020027
    👥 Contributors: Jonathan Lee-Confer, Lila Wayman, Kathryn L. Havens

  2. Standardized Measurement of Surface Dry Particle Thickness for Walkway Slip Resistance
    📅 Published: May 19, 2025
    🧪 Journal: Journal of Forensic Sciences
    🔗 DOI: 10.1111/1556-4029.70087
    👥 Contributors: Jonathan Lee‐Confer, Lila Wayman, David Collette

  3. Standardized Measurement of Surface Dry Particle Thickness for Walkway Slip Resistance (Preprint)
    📅 Posted: February 24, 2025
    🔗 DOI: 10.31224/4398
    👥 Contributors: Jonathan Lee-Confer, Lila Wayman, David Collette

  4. The Influence of Sand Additives on Slip Resistance of Wood (Preprint)
    📅 Posted: February 4, 2025
    🔗 DOI: 10.31224/4339
    👥 Contributors: Jonathan Lee-Confer, Lila Wayman, Kristen Renner

  5. High G-Forces in Unintentionally Improper Infant Handling: Implications for Shaken Baby Syndrome Diagnosis (Preprint)
    📅 Posted: November 3, 2024
    🔗 DOI: 10.1101/2024.10.31.621215
    👥 Contributors: Jonathan Lee-Confer, Lila T. Wayman, Kathryn Havens

 

Yuchun Wei | Medicine and Health Sciences | Best Researcher Award

Assoc. Prof. Dr. Yuchun Wei | Medicine and Health Sciences | Best Researcher Award

Shandong Cancer Hospital China

Dr. Yuchun Wei is a leading Chinese physician-scientist in the field of oncology and nuclear medicine, currently working at the Shandong Cancer Hospital in Jinan, China. Born on November 22, 1987, she has contributed significantly to developing innovative imaging techniques for cancer diagnosis, staging, and individualized treatment planning. With deep expertise in PET/CT imaging biomarkers, she is committed to advancing precision oncology. 📡🧬

Profile

Scopus

Orcid

🎓 Education

Dr. Wei pursued her academic journey with a strong foundation in both Western and traditional Chinese medicine:

  • Ph.D. in Oncology from Shandong University (2018–2022), mentored by Academician Jinming Yu 🎓
  • Master’s in Oncology from Jinan University (2013–2016), under Prof. Shuanghu Yuan 🔬
  • Bachelor’s in Traditional Chinese and Western Clinical Medicine from Shandong University of Traditional Chinese Medicine (2007–2012) 🌿

💼 Professional Experience

Dr. Wei currently serves as a radiotherapy physician at Shandong Cancer Hospital (2017–present). She has also held several administrative and research leadership roles:

  • Deputy Director, MDT Quality Management Office (2021–2022)
  • Assistant Director, Radioimmunity and Molecular Imaging Room (2020–2021)
    Her clinical expertise is complemented by her operational leadership in multidisciplinary cancer care. 🏥⚕️

🔬 Research Interests

Her research revolves around novel imaging techniques, especially FAPI-based PET/CT imaging, with a focus on early detection, prognosis prediction, and therapy monitoring for cancers such as lung, esophageal, and cervical. Her goal is to refine personalized cancer treatment through quantitative imaging biomarkers. 🔍📊

🏆 Awards & Honors

Dr. Wei has been nominated for multiple research and innovation awards in recognition of her work in molecular imaging and radiation oncology. Her studies have earned significant visibility in top-tier journals (JCR Q1), and she is regarded as a rising star in clinical translational imaging. 🌟

📚 Publications Top Notes: 

Dr. Wei has authored and co-authored over 17 high-impact peer-reviewed papers, most of which appear in JCR Q1 journals. Here are her key publications with direct links and citation highlights:

FAPI Compared with FDG PET/CT for Lung Cancer Diagnosis
Radiology, 2023, IF: 19.7 | Cited by: 33

18F-FAPI PET/CT in Esophageal SCC Response Prediction
J Nucl Med, 2024, IF: 9.1 | Cited by: 12

Early Detection of Radiation-Induced Myocardial Damage
Eur J Nucl Med Mol Imaging, 2023, IF: 10.057 | Cited by: 40

18F-FAPI PET/CT Response in Chemoradiotherapy for ESCC
J Nucl Med, 2023, IF: 11.082 | Cited by: 25

Biodistribution and Targeting of 18F-FAPI-04
Eur J Nucl Med Mol Imaging, 2022, IF: 10.057 | Cited by: 37

Differentiating Lung Cancer Types via PET/CT
Eur J Nucl Med Mol Imaging, 2022, IF: 10.057 | Cited by: 31

Baseline Angiogenesis in NSCLC Prognosis
J Transl Med, 2022, IF: 8.44 | Cited by: 19

Differentiating Inflammatory Lung Lesions with FAPI
Eur Radiol, 2023, IF: 5.9 | Cited by: 10

Comparison Study in Mouse Model using PET Imaging
Sci Rep, 2016, IF: 5.228 | Cited by: 50

Radiation-Induced Lung Damage Model in Rats
Front Oncol, 2022, IF: 5.738 | Cited by: 14